Uh oh we’ve got someone mad at me in the replies because he took a gamble and didn’t stop to read the chart…
We’re still seeing $SPX holding onto from that cliff I mentioned. Price is under the cliff so I would not be shocked by 5860 upon closing, about 585 on $SPY
Now 5907
Reason that convinced me-
$WBA may be one of the most overlooked turnaround stories in the market today. Trading at historically low valuation multiples, WBA offers a compelling mix of defensive cash flow, structural transformation, and contrarian upside potential.
- Historically Low Valuation
- Healthcare Transformation Strategy
•Walgreens is shifting from a traditional pharmacy retailer to a healthcare services provider.
•Through partnerships (e.g., VillageMD, CareCentrix) and acquisitions, it’s building out primary care clinics, in-home care services, and value-based healthcare—tapping into a $1 trillion+ healthcare market.
• This long-term pivot could dramatically improve margins and open new, recurring revenue streams.
- Cost Cutting + Operational Efficiency
•The company has announced a $1 billion cost-saving plan by 2025.
• Recent leadership changes are prioritizing operational discipline and digital transformation, which should drive margin improvement.
Elon can shadowban this account all he wants. The volume of insight I have in my tweets is plentiful
$SPY $SPX $WBA
Look up a bullish ticker in my tweets, I was probably on it EARLY. 🔌
e.g. $PLTR 🤫
$CRSP could be worth $100 in the next 3-6 months
The first time I heard about CRISPR (7 years ago in a Genetics course) it seemed meta to use nanotechnology for gene editing.
I see it again in med school and it’s being taught as a way to increase fetal hemoglobin production.
@hypergrowth102 I own a small position in $CRSP. The company has FDA clearance for sickle cell disease, a first-mover advantage, a solid balance sheet, and a strong partnership with Vertex Pharmaceuticals.
$WBA is looking great
39¢ reported EPS vs 35.8¢ expected
5.02% Revenue surprise
No wonder the high today was $10.64
If $SPY goes green Walgreens takes stride for the $12 level
We might have the next big squeeze here
PORT STRIKE COULD HIT HALF OF U.S. IMPORTS
Many importers and manufacturers pulled forward orders over the summer to try to get ahead of the looming East Coast port strike now underway. But if not resolved soon, the strike could eventually affect the shipping of 40% to 50% of U.S. imports, S&P Global Market Intelligence writes. Those disruptions would surely put upward pressure on goods prices, S&P notes, complicating the Fed's ambition to wind down its fight against inflation. Higher shipping costs to the East Coast in anticipation of the strike have already contributed an inflationary impulse, S&P notes.
549 is breached, as expected.
Now 548.67
545 is a feasible closing price given the 🔑 level of 540 is of interest now.
$SPY continuing in RED
Let’s bleed $3 more 🩸🩸🩸